Showing results (21-30 of 435) with videos related to
Sort By:
Pageof 44
PET Clinics|May 16, 2019
PET-Computed Tomography in Myeloma: Current Overview and Future DirectionsDeepu Madduri, Bart BarlogieBlood|July 26, 2014
CYR61/CCN1 overexpression in the myeloma microenvironment is associated with superior survival and reduced bone diseaseSarah K Johnson, James P Stewart, Rakesh Bam, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 21, 2010
Long-term follow-up of autotransplantation trials for multiple myeloma: update of protocols conducted by the intergroupe francophone du myelome, southwest oncology group, and university of arkansas for medical sciencesBart Barlogie, Michel Attal, John Crowley, et al.Blood|November 11, 2011
An intermediate-risk multiple myeloma subgroup is defined by sIL-6r: levels synergistically increase with incidence of SNP rs2228145 and 1q21 amplificationOwen W Stephens, Qing Zhang, Pingping Qu, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 10, 2006
Using genomics to identify high-risk myeloma after autologous stem cell transplantationJohn D Shaughnessy, Bart BarlogieInternational Journal of Hematology|November 15, 2002
Early results of total therapy II in multiple myeloma: implications of cytogenetics and FISHBart Barlogie, John D ShaughnessyInternational Journal of Hematology|November 15, 2002
Integrating cytogenetics and gene expression profiling in the molecular analysis of multiple myelomaJohn D Shaughnessy, Bart BarlogieImmunological Reviews|July 9, 2003
Interpreting the molecular biology and clinical behavior of multiple myeloma in the context of global gene expression profilingJohn D Shaughnessy, Bart BarlogieBritish Journal of Haematology|April 7, 2009
Cytogenetic abnormalities in multiple myeloma: poor prognosis linked to concomitant detection in random and focal lesion bone marrow samples and associated with high-risk gene expression profileYiming Zhou, Bijay Nair, John D Shaughnessy, et al.British Journal of Haematology|February 28, 2008
Sustained complete remissions in multiple myeloma linked to bortezomib in total therapy 3: comparison with total therapy 2Mauricio Pineda-Roman, Maurizio Zangari, Jeff Haessler, et al.Pageof 44